GLP-1 Insights
Unified tracking for GLP-1 medication journey and biometrics
Software · Cloud SaaSCompany source
Company profile
About Oura
Oura Health Oy is a consumer health technology company that manufactures the Oura Ring, a compact wearable smart ring designed for continuous health monitoring. The company's flagship product tracks over 50 health metrics including sleep quality, activity levels, heart rate variability, stress indicators, and cardiovascular signals. The Oura Ring is designed to be worn 24/7 on the finger, which the company states provides the most accurate biometric readings compared to other wearable locations. The Oura platform combines hardware with a subscription-based membership that provides access to the Oura App, which translates raw biometric data into actionable health insights through daily Readiness, Sleep, and Activity scores. Recent software innovations include Health Radar for proactive health monitoring, Live Activity Tracking for real-time workout metrics, GLP-1 Insights for medication management, and enhanced data privacy controls. Oura serves health-conscious consumers seeking to optimize sleep, manage stress, improve fitness, and monitor overall wellness. The company has achieved significant market traction with celebrity and executive endorsements, and reached an $11 billion valuation in 2025. Oura's technology is FSA/HSA eligible and integrates with various health platforms. The company emphasizes accuracy, user privacy, and continuous innovation in wearable health technology, positioning itself as a leader in the smart ring category ahead of potential competition from major tech companies.
Company description Oura official website
Primary marketRemote Patient Monitoring & Wearables
Commercial modelCommercial information available on request
Company presenceX
Work at Oura?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Cardiovascular health monitoring
- Metabolic health
- Respiratory patterns during sleep
- Sleep disorders
- Stress management
- Women's health conditions
Who it serves
- Individual consumers
- Organizations (B2B offering mentioned)
Deployment & integration
Cloud Saas · Embedded deployment with recorded integration context.
Recorded integration context: Counsel Health (AI-enabled primary care platform), LillyDirect (GLP-1 therapy support), Various health platforms (unspecified).
Geographic context
MarketsGlobal (app available in 20+ languages) · India · United Arab Emirates · United States
Company sourceOfficial website
Company milestones
Platform expansion
Launched Oura Ring 5 (May 2026), introduced Health Radar proactive monitoring, reached $11 billion valuation with $900 million fundraise (2025), launched GLP-1 Insights (June 2026), introduced Live Activity Tracking (June 2026)
Partnerships
Recorded partners
- Counsel Health
- LillyDirect (Eli Lilly)
- Stelo Glucose Biosensor
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Health Radar
Proactive health monitoring that surfaces patterns worth attention
Software · Cloud SaaSCompany source
Live Activity Tracking
Real-time workout tracking with lock screen widgets
Software · Cloud SaaSCompany source
Oura Membership
Evolving member experience with expanded features and insights
Platform · Cloud SaaSCompany source
Oura Ring 4
Smart ring for fitness, stress, sleep and health tracking
Device · EmbeddedCompany source
Oura Ring 5
The world's smallest smart ring for comprehensive health tracking
Device · EmbeddedCompany source
Stelo Glucose Biosensor
Glucose monitoring biosensor integrated with Oura ecosystem
Device · EmbeddedCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Revisiting the role of beta-amyloid precursor protein immunoreactivity in the neuropathological diagnosis of hypoglycaemia.Forensic science international · Aug 26, 2026
The Effects of AI-Guided Exercise and a Smart Ring on Arterial Stiffness: Protocol for a Randomized Controlled Trial.JMIR research protocols · Aug 21, 2026
Deep Learning-based Automated Vessel Extraction for VR Image Creation From Cerebral TOF-MRA.Academic radiology · Aug 8, 2026
Corrigendum to "Use of nanobubble water bioaugmented anaerobically digested sludge for high-efficacy energy production from high-solids anaerobic digestion of corn straw" [Sci. Total Environ. 863 (2023) 160825].The Science of the total environment · Jul 30, 2026
Using a Fine-Tuned Commercial Artificial Intelligence Model to Assess Nutrients from Photographs of Japanese Meals.Journal of diabetes science and technology · Jul 6, 2026
Avoiding variability in sleep variability assessments: how many nights are enough?Sleep · Jun 15, 2026
Clinical validation
Clinical-trial records
Continuous Wearable Biometric Monitoring in Adults Undergoing Obesity Treatment (SMART-BMI)NCT07736729 · Sponsor · NOT YET RECRUITING
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
50+ health metrics tracked
Continuous biometric monitoring
6-9 days battery life
Oura Ring 5 single charge duration
40+ activities detected
Automatic activity detection accuracy
Jussi L.
Daily health tracking and guidance
Oura has become daily compass, keeping on the right track
Linda D.
Data-driven health decision making
Oura data serves as form of guided decision-making
Rhonda C.
Sleep improvement and healing journey
Oura was the first step in improving sleep and start of healing journey
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Oura
Recent articles published on Oura's official website.
The Science Behind Consumer Wearable Sleep Technology, According to a Sleep Scientist
Read on Oura“I Might Not Have Woken Up:” Tim’s Oura Story
Read on OuraOura’s Automatic Activity Detection: More Accurate Than Ever
Read on OuraCoco Gauff and Taylor Fritz Join ŌURA as Brand Ambassadors Ahead of the 2026 US Open
Read on Oura07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
Lab-Grown Blood Vessels Show Promise in Reversing Heart Disease Damage
Preclinical studies reveal engineered vascular organoids can integrate with damaged heart tissue and restore blood flow, offering a regenerative alternative to traditional bypass surgery.
Clinical AI · Jul 3, 2026
Can Rheumatoid Arthritis Be Stopped Before It Starts? Landmark Trial Shows 60% Prevention Success
A groundbreaking UK study demonstrates that early intervention with an existing drug can prevent the onset of debilitating autoimmune disease in high-risk patients, opening the door for AI-powered predictive screening.
Clinical AI · Jul 3, 2026
Vietnam's Health Insurance Overhaul Creates Blueprint for AI-Driven Universal Coverage
New regulations expanding coverage caps, telemedicine reimbursement, and chronic disease benefits position Vietnam as a testing ground for digital health equity solutions.
Health Equity & Access · Jul 3, 2026
The FDA’s Bayesian Guidance Could Quietly Reshape Clinical Trial Design
FDA's new guidance on Bayesian statistical methods opens the door to adaptive clinical trials that could accelerate drug development while reducing costs and patient exposure to ineffective treatments.
Policy & Regulation · Jun 18, 2026
Why Drug Trials Are About to Get Smarter: FDA Embraces Statistical Revolution That Could Save Years of Research
FDA's new guidance on Bayesian statistical methods opens the door to adaptive clinical trials that could accelerate drug development while reducing costs and patient exposure to ineffective treatments.
Policy & Regulation · Jun 17, 2026
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Remote Patient Monitoring & Wearables
Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.